Dhargam Aljebouri: A New Milestone for Transfusion Education in Iraq
Dhargam Aljebouri, Laboratory Director at Clinical Immunology, Allergy and Transfusion Medicine – Specialized Immunosciences Laboratory, shared a post on LinkedIn:
”I was pleased to meet with Yaqoob Al-Mousawi, Director of the National Blood Transfusion Center, Baghdad, Iraq, together with colleagues, to discuss the scientific and organizational preparations for our upcoming International Society of Blood Transfusion (ISBT) Academy-supported educational activity: Advancing immunohematology and Transfusion Safety in Iraq: A One-Day Case-Based Educational Workshop for Transfusion Professionals
During the meeting, we reviewed the key components of the programme, including the scientific sessions, participant selection process, educational objectives, evaluation strategy and post-workshop learning follow-up.
This activity represents an important milestone for transfusion medicine education in Iraq, particularly as it is the first hashtag#ISBT Academy-supported educational activity in the country since the establishment of national blood transfusion services.
I am grateful to Yaqoob Al-Mousawi and the National Blood Transfusion Center for their leadership, support and commitment to strengthening professional education in transfusion medicine.
Looking forward to a meaningful and impactful educational day on 14 November 2026.
Dhargam Aljebouri
Scientific Coordinator and Lead Speaker.”
Stay updated with Hemostasis Today.
-
Oct 16, 2026, 16:22Shannon Farmer: Driving Patient Blood Management Forward in Australia and New Zealand
-
Oct 16, 2026, 16:01Obi Light Ogbonnia: The Greatest Reward Is Changing Lives, Not Winning Awards
-
Oct 16, 2026, 15:18Carmine Liberatore: Limited Accuracy of VTE Risk Scores in Multiple Myeloma
-
Oct 16, 2026, 14:55Alex Borstein and the Bleeding Phenotype of Hemophilia A Carriers
-
Oct 16, 2026, 13:59Aya Akmal Amin: Antiphospholipid Syndrome Management and Risk Stratification
-
Oct 16, 2026, 13:10Emanuel Sueldo: CAHT 2026 Celebrates Scientific Progress and Team Achievements
-
Oct 16, 2026, 13:05Maha Othman: Queen’s Health Sciences Advances CAT Risk Models and Pediatric ISTH-BAT Cut-Offs
-
Oct 16, 2026, 13:03Thrombosis Awareness Must Lead to Timely Action – Roche
-
Oct 16, 2026, 12:49Wolfgang Miesbach: 5-Year CBDR Data Confirms Emicizumab Safety and Efficacy in Hemophilia A